Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
Stepping into the Unscientific
Chapter 810

The Distributor's Choice

2,370 words 8 min read 1 view 1mo ago Source ​
Skip to the end of the chapter
Prev
Next

"Export license to the EU?"

Upon hearing Academician Pan's words, Xu Yun was stunned for a few seconds.

After all, he had just spent almost two years in the "Two Bombs, One Satellite" scenario, and some of his memories of reality were already a bit hazy.

However, he soon recalled the situation that Academician Pan had mentioned.

At the time, several foreign companies, led by Advion, deliberately orchestrated a Public opinion campaign to destroy Xu Yun's reputation by accusing her of cat abuse and abortion in order to thwart the "Yi Ge Lang Mie" strategy.

However, Xu Yun and University of Science and Technology of China later turned the tables with various solid evidence, one of the most powerful weapons being the online meeting recordings that Gareth Touré of Valeni Pesticide Company gave to the Rabbits.

The video contained footage of several foreign company executives, as well as their plans to manipulate Public opinion regarding Xu Yun.

This footage had a significant impact on the stock prices of several foreign companies after the press conference. In order to quell the controversy as soon as possible, the foreign companies not only dismissed the attendees but also jointly provided some compensation to Huadun Biotech.

The compensation included an agreement to safely repatriate Lu Xiao, who is now the head of the MR project at Huadun Biotech, and also to secure the qualification to export 'Yi Ge Lang Mie' to the European Union.

You need to know.

Although Huaxia has become the world's largest producer of pesticides, with exports accounting for over 70% of its total output, it is still a formidable challenge.

However, the pesticides mentioned here mainly refer to glyphosate, which is a non-selective herbicide, accounting for as much as 54%.

For most domestically produced chemical pharmaceuticals, especially nerve-related insecticides which are technically challenging, exporting to the EU is no easy task.

Because the requirements for it from Europe and America are just too high.

The threshold for insecticides and pest control devices is called CE certification. This hurdle is actually quite easy to pass, as long as the product does not endanger human or animal safety.

The national standard for this is GB4706.76, and the international standard is IEC 60335-2-59.

If we really compare, the requirements in China are actually a bit higher.

But just as passing the first-tier university entrance exam doesn't guarantee admission to Tsinghua or Peking University, even after passing the CE certification hurdle, there's still the EU market entry standard to overcome.

Market access criteria require an assessment of inactive substances. If the target substance is not on the exemption list, it needs to undergo EU chemical registration assessment authorization and EU REACH regulation registration.

Besides that.

The Europe Chemicals Agency also requires that suppliers of active ingredients be included in the qualified supplier list, namely the corresponding disinfectant products under Article 95, before they can be placed on the EU market.

The entire process involved many opaque steps, which, to put it bluntly, was heavily influenced by politics.

This process is completely beyond the scope of Huadun Biotech's capabilities at present.

Therefore, the export qualifications submitted by these foreign companies are, without exaggeration, a priceless gift.

After all, exports bring in huge profits!

Even with tariffs and shipping costs added to the process, the exchange rate between the Huaxia currency and foreign currencies is such that Huadun Biotech will not lose money no matter what.

"."

Then Xu Yun wiped away non-existent drool from the corner of his mouth and said to Academician Pan:

"Teacher, once the license is issued, does that mean our products can be sold overseas immediately?"

"Look, you're in such a hurry again."

Upon hearing this, Academician Pan smiled and nodded at Xu Yun, appearing every inch the elder who might recite poetry at any moment.

"Although your company has now obtained its drug export license, there are still many procedures to go through. For example, the factory's qualifications, namely GMP and GDP, still need to be confirmed, right?"

"For example, when your products are exported to Europe, shouldn't you first establish a relationship with the importer?"

"Although these processes are assisted by the Chinese Academy of Sciences and foreign companies like Bayer, at most they can ensure that the processes are not rejected by political factors; the time required is still unavoidable."

Xu Yun pondered for a moment, then finally nodded slightly.

Too.

I got a little anxious.

The export process for chemical pharmaceuticals is very complicated. Bayer only helps with two types of directives: Directive 2001/83/EC and Regulation (EC) No 726/2004. In short, it's about the review of the drug itself.

This part of the Centralised Procedure consists of four components: the Centralized Procedure, the Decentralised Procedure, the Mutual Recognition Mutual Recognition Procedure, and the National Procedure.

In addition to reviewing the drug's ingredients and efficacy, the manufacturer's own qualifications and certifications are also subject to review.

For example, GMP and GDP, which Academician Pan mentioned, refer to Good Manufacturing Practices and Good Manufacturing Practices for pharmaceuticals.

In addition, after the drug obtains European approval, Huadun Biotech still needs to find cooperative distributors and set prices, which also requires some negotiation.

Note that the distributors here do not refer to pharmaceutical companies, but rather to intermediaries between businesses and pharmacies.

In the early years Huaxia's Kangwang and Piyanping products promoted the regional distributor model. However, those distributors were usually individuals carrying out distribution and promotion, which was relatively primitive.

In Europe and America, large-scale distributors are often not much smaller than pharmaceutical companies. They control a large number of pharmacies and hospitals, making them local bigwigs.

Reliable distributors can usually provide a wide distribution channel, but their intermediary fees will certainly not be low. Similarly, if you want to find a distributor with a low commission rate, you have to bear the risk of a narrow sales channel or even the other party running away with your money.

Therefore, choosing a distributor is also an issue that needs to be considered.

Xu Yun then thought for a moment and asked Academician Pan:

"Teacher, do you have any recommendations regarding distributors?"

"I recommend it!"

Academician Pan stroked his chin and asked:

"Little Xu, let me clarify one thing first. The distributor you're looking for should be domestic or state-owned, right?"

Xu Yun nodded; he did indeed place more emphasis on state-owned distributors.

After all, with companies like Bayer guaranteeing they wouldn't interfere politically, 'Yi Ge Lang Mie's' long-term sales in Europe are bound to be quite high.

Given the historically high commission rates in cross-border trade, the money that ends up in the hands of distributors is no small sum.

In this situation, Xu Yun would definitely prefer to make money for the national team.

Of course.

The reason why it is only a preference rather than a requirement for state-owned distributors is mainly because Xu Yun is not yet sure about the current capabilities of state-owned distributors. If a distributor has a state-owned background but can only distribute 10,000 to 20,000 cockroach baits a year, Xu Yun would definitely not choose it, and the company's Board of Directors would certainly not agree.

Xu Yun's bottom line is 15% of the existing distribution capacity of major Europe distributors.

If a 15% market share can be achieved, Xu Yun is willing to sacrifice some of the product's adoption rate to work with state-owned distributors to expand their influence in the Europe chemical industry, which would be considered as contributing within their capabilities.

But if even this ratio can't be reached, frankly, there's no point in discussing it.

Let's return to reality.

After receiving Xu Yun's reply, Academician Pan pondered for a moment. As someone outside the pharmaceutical industry, he was able to offer some relatively fair comments at this point:

"Little Xu, you should be prepared that the scale of state-owned distributors in the European and American markets is relatively limited at present."

"After all, many Western medicine patents are now held by European and American pharmaceutical companies. I heard a report on this when I attended the Chinese Academy of Sciences executive meeting last year. Currently, the main categories of drugs we export are only insulin, eye drops, and anesthetic drugs, as well as some mid-range medical consumables."

"So, to be honest, the state-owned distributors you're looking for don't have many options."

As he spoke, Academician Pan counted on his fingers:

"The top one is definitely the Europe distribution company of Guo Yi Group), followed by Yangzijiang Pharmaceutical Group, Guangzhou Pharmaceutical Holdings Group, Hengrui Medicine, and Fosun Pharma. I also remember that Chia Tai Tianqing Pharmaceutical Group has a considerable presence in Europe. That's about it."

Xu Yun took a pen and wrote down the names of the companies that Academician Pan mentioned. After glancing at them, he crossed out Yangzijiang Pharmaceutical Group and Fosun, eliminating them from the list.

Seeing this, Academician Pan blinked and asked with some curiosity:

"Little Xu, why did you delete those two?"

Xu Yun looked up at his teacher, then circled the two names with his pen:

"I don't really like some of the former's business tactics, and the latter's shareholding situation is a bit complicated, so let's just forget about it."

Considering that Academician Pan was, after all, his mentor, Xu Yun's words were actually quite tactful.

To be honest, he personally doesn't have a good impression of either of these companies.

First and foremost, Yangzijiang Pharmaceutical Group certainly has strong R&D capabilities. Its Yangtze River Su Huang Zhi Ke remedy is arguably one of the most effective traditional Chinese medicines on the market. However, Yangzijiang Pharmaceutical Group has a habit of giving doctors exorbitant commissions.

For example, its Levamlodipine besylate is seven or eight times more expensive than regular amlodipine, and the kickbacks it gives to doctors are as high as two yuan per box.

In addition, the rebates for Naoxintong Capsule and Wenxin Granules are also very high, and their Dizosin can even be used at the highest rate in many hospitals.

In 2021, Yangzijiang Pharmaceutical Group was fined 764 million yuan by the State Food and Drug Administration for monopolistic practices.

Therefore, this is a very complex pharmaceutical company. It certainly has the capability, but at the same time, it has significantly increased the medical costs for patients.

As for Fosun Pharma, that's a matter of its shareholding structure.

Fosun Pharma is a typical investment company disguised as a pharmaceutical company. Many of its products are developed and manufactured by its subsidiaries, while the holding group's R&D capabilities are generally average.

Therefore, you will find that its stock price fluctuates most of the time. When there is a positive event, the stock price will rise, and vice versa.

Several of those foreign companies were Xu Yun's "old acquaintances," and they accounted for a significant portion of his business, so Xu Yun certainly wouldn't want them to make money.

Seeing Xu Yun's resolute expression, Academician Pan quickly nodded as well:

"If you deleted it, you deleted it. As long as you know what you're doing."

"As for the remaining companies, I would recommend Hengrui and Chia Tai Tianqing."

"Oh?"

Xu Yun raised an eyebrow:

"The Chia Tai Tianqing?"

It was within Academician Pan's expectations that Hengrui would be recommended. After all, Hengrui is a well-known innovative drug company with extremely high annual R&D investment. In the public eye, it has a positive image as a pioneer and is considered Longtou among domestic pharmaceutical companies.

But Xu Yun was a little surprised by the Chia Tai Tianqing.

Xu Yun didn't know much about Chia Tai Tianqing. In fact, when he heard the name Chia Tai, his first thought was Grand Variety Show, and only then would he think of this domestic "Little Four".

However, Xu Yun's surprise was within Academician Pan's expectations; he simply smiled calmly.

"Little Xu, don't let Chia Tai Tianqing's relatively small brand name fool you; it's actually doing quite well in the overseas distribution sector."

"It is actually a core enterprise under Huaxia Biopharmaceutical. Thailand hold shares, but the proportion is not large, and they are from a Thai-Chinese family, namely the Xie family of the CP Group."

"Among the current state-owned distributors in Europe, Chia Tai Tianqing ranks third in annual distribution volume and second in profit margin—of course, this is related to the fact that it mainly exports medical consumables. Given its limited scale, the gross profit margin of consumables is definitely higher than that of pharmaceuticals."

Xu Yun then understood.

I see

These days, it's really hard to find a pure-blooded company like Huadun Biotech, let alone in a field like multinational e-commerce. Therefore, it's tolerable for companies like Chia Tai Tianqing to have a relatively low level of foreign investment—as long as state-owned capital accounts for the majority.

The reason he previously abandoned Fosun was because the proportion of foreign investment was too high.

Moreover, he has a good impression of the CP Group. Its founders Xie Yichu and Xie Shaofei, went to Southeast Asia in the 1920s to make a living, which is fundamentally different from Runren.

After investing in Huaxia Land Development, CP Group sponsored Grand Variety Show, invested in Dayang Motorcycle, and generously donated money during various disasters. As of March 2024, it had not yet encountered any problems.

"Oh, right."

Then Academician Pan seemed to remember something and pointed to the handwritten list in front of Xu Yun, saying:

"If I remember correctly, Academician Tian's junior colleague just joined the distribution department of Chia Tai Tianqing Pharmaceutical Group."

"If you can reach an agreement with them, you should be able to get a good middleman price, and you'll also do them a favor, so it's a win-win situation."

Xu Yun was stunned for two seconds upon hearing this:

"Academician Tian, you mean Director Tian?"

Academician Pan nodded.

The Academician Tian he mentioned was Tian Liangwei, Xu Yun's mentor in biology. Previously, when Academician Pan was discussing Xu Yun's dissertation defense arrangements with Tian Liangwei, they happened to meet Tian Liangwei, who was visiting them.

At the time, the other party's purpose was to discuss some student recruitment cooperation with the University of Science and Technology of China School of Medicine, so Academician Pan did not ask too many questions, but he kept it in mind.

Unexpectedly, the timing is so convenient now, it seems there's an opportunity to do someone a favor?

I've also heard of Academician Pan, Tian Liangwei's junior colleague. He's quite capable and of good character, but instead of pursuing scientific research, he went into business operations and has accumulated a considerable fortune over the past twenty years.

"."

Across from Academician Pan, Xu Yun's gaze swept across the paper several times before he clapped his hands forcefully:

"Okay, then we'll choose Chia Tai Tianqing!"

Note:

Yesterday I took a high-speed train for several hours, and the guy next to me took off his shoes and went barefoot; the smell was awful.

At the request of several influential figures, a new "Alliance Leader" group has been created. Those who meet the required follower count are welcome to join. The regular group has also been unlocked.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Xu Yun
Huaxia
Rabbits
Academician Pan

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS